A Two-Compound Product Containing Calcipotriol and Betamethasone Dipropionate Provides Rapid, Effective Treatment of Psoriasis vulgaris regardless of Baseline Disease Severity

Publisher： Karger

E-ISSN： 1421-9832|210|4|294-299

ISSN： 1018-8665

Source： Dermatology, Vol.210, Iss.4, 2005-05, pp. : 294-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

By  

Dermatology, Vol. 213, Iss. 4, 2006-12 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

Treatment of Nail Psoriasis with a Two-Compound Formulation of Calcipotriol plus Betamethasone Dipropionate Ointment

By  

Dermatology, Vol. 218, Iss. 4, 2009-02 ,pp. : 338-341

Karger

Access to resources Recommend Favorite

A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

By  

Dermatology, Vol. 205, Iss. 4, 2002-12 ,pp. : 389-393

Karger

Access to resources Recommend Favorite

Cost-Effectiveness of Once-Daily Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol in the Treatment of Psoriasis vulgaris

By  

Dermatology, Vol. 211, Iss. 2, 2005-08 ,pp. : 139-145

Karger

Access to resources Recommend Favorite

Efficacy of Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol for the Treatment of Psoriasis vulgaris: A Randomised, Double-Blind Trial

By  

Dermatology, Vol. 209, Iss. 4, 2004-12 ,pp. : 308-313

Karger

Access to resources Recommend Favorite